Clinical Trial Update: An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS Dependence [Phase 3]

View source ↗

Summary

An open-label Phase 3 trial evaluating paliparidone for co-occurring opioid use disorder (heroin dependence) and amphetamine use disorder; current status is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amphetamine Use Disorder
• Opioid Use Disorder

Drugs mentioned

• Paliparidone (Paliparidone)

Snippet

Sponsor: Universiti Sains Malaysia | Conditions: Heroin Dependence, Amphetamine Dependence | Phase 3 | Status: UNKNOWN